News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
20
2024
-
09
Academic development! Keyuan Pharmaceuticals & LiNuo Pharmaceuticals Invited to Attend the 2024 Allergy Academic Conference!
Classification：
News
行业新闻
Corporate News
Recently,2024 National Allergy ConferenceHeld in Guangzhou, Keyuan Pharmaceutical (stock code: 301281.SZ) & lino pharmaceutical as an outstanding representative of the pharmaceutical industry,Bring cutting-edge scientific research results and exclusive products to the sceneTo contribute to the construction of academic highlands.
This conference is sponsored by the Chinese Medical Association and brings together professionals in various fields of allergy.scholars, medical workers, researchers and graduate students,It aims to build an important platform for exchanging knowledge, sharing experience and discussing the progress of the discipline,Discuss the latest progress and future development direction of the discipline together.
During the meeting, representatives of Keyuan Pharmaceutical and lino Pharmaceutical actively participated in relevant forums and seminars, and worked with colleagues from all over the country.The future development direction and incremental market of allergology are discussed together.
Keyuan PharmaceuticalChairman and President Jiang HongshengLed the team to have in-depth exchanges with many industry leaders and academic experts,Discuss the future development trend and cooperation opportunities of health industry.A number of industry experts on Keyuan Pharmaceuticals and lino Pharmaceuticals.Development achievements expressed high recognitionand expressed their willingness to cooperate.
In the field of allergy, Keyuan Pharmaceuticals and lino Pharmaceuticals have demonstrated strongscientific research strength and innovation ability. At this meeting, Keyuan Pharmaceutical and lino pharmaceutical brought solutions for allergic diseases, which were highly concerned and recognized by experts and scholars attending the meeting.
As a pioneer in the transformation of digital intelligence in the domestic health industry, Keyuan Pharmaceuticals & Lino Pharmaceuticals has been in recent years.Remarkable achievements have been made in drug research and development, production, sales and medical services.The company actively explores the application of digital and intelligent technology in drug research and development,A large number of the introduction of the world's leading automatic production equipment and production management system, to realize the digital management of the whole business process, effectively improve the production efficiency, product quality and management efficiency.
With the aging of the population and consumer health awareness,Allergology as a subject involving a wide range of far-reachingThere will be a broader space for development. Keyuan Pharmaceuticals & lino Pharmaceuticals will keep pace with the times,Continuously increase investment in research and development and market expansion,To contribute more to the high-quality development of allergology.
The successful holding of this allergic reaction academic conference, not onlyIt provides an important platform for colleagues in the industry to exchange ideas and share results., more many excellent enterprises provideDemonstrate strength and expand cooperationof opportunity. I believe that in the future development, Keyuan Pharmaceutical & lino pharmaceutical will continue to uphold the spirit of innovation,constantly break through the self,To make greater contributions to building academic highlands and promoting the high-quality development of the health industry.
Related news
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China
